Rho gtpases: Novel players in the regulation of the DNA damage response?

Biomolecules

Volumn 5, Issue 4, 2015, Pages 2417-2434

  Fritz, Gerhard ^a   Henninger, Christian ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anticancer drugs; Chemical carcinogenesis; DNA damage response; Genotoxic stress; HMG CoA reductase inhibitors (statins); Normal tissue damage; Rho GTPases

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ATM PROTEIN; ATR PROTEIN; MEVINOLIN; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SIMVASTATIN; ANTINEOPLASTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

APOPTOSIS; CELLULAR STRESS RESPONSE; COLORECTAL CANCER; DNA DAMAGE; GENE EXPRESSION; HUMAN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA DAMAGE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 85012078038     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5042417     Document Type: Review

References (124)

1. Bar-Sagi, D.; Hall, A. Ras and Rho GTPases: A family reunion. Cell 2000, 103, 227–238
2. Etienne-Manneville, S.; Hall, A. Rho GTPases in cell biology. Nature 2002, 420, 629–635
3. Wennerberg, K.; Rossman, K.L.; Der, C.J. The ras superfamily at a glance. J. Cell Sci. 2005, 118, 843–846
4. Bourne, H.R.; Sanders, D.A.; McCormick, F. The GTPase superfamily: Conserved structure and molecular mechanism. Nature 1991, 349, 117–127
5. Zhang, B.; Chernoff, J.; Zheng, Y. Interaction of Rac1 with GTPase-activating proteins and putative effectors. A comparison with Cdc42 and RhoA. J. Biol. Chem. 1998, 273, 8776–8782
6. Bishop, A.L.; Hall, A. Rho GTPases and their effector proteins. Biochem. J. 2000, 348, 241–255
7. Schwartz, M. Rho signalling at a glance. J. Cell Sci.2004, 117, 5457–5458
8. Iden, S.; Collard, J.G. Crosstalk between small GTPases and polarity proteins in cell polarization. Nat. Rev. Mol. Cell Biol. 2008, 9, 846–859
9. Kjoller, L.; Hall, A. Signaling to Rho GTPases. Exp. Cell Res.1999, 253, 166–179
10. Van Aelst, L.; D’Souza-Schorey, C. Rho GTPases and signaling networks. Genes Dev. 1997, 11, 2295–2322
11. Adamson, P.; Marshall, C.J.; Hall, A.; Tilbrook, P.A. Post-translational modifications of p21Rho proteins. J. Biol. Chem. 1992, 267, 20033–20038
12. Adamson, P.; Paterson, H.F.; Hall, A. Intracellular localization of the p21Rho proteins. J. Cell Biol.1992, 119, 617–627
13. Hoffman, G.R.; Nassar, N.; Cerione, R.A. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator Rhogdi. Cell 2000, 100, 345–356
14. Olofsson, B. Rho guanine dissociation inhibitors: Pivotal molecules in cellular signalling. Cell Signal 1999, 11, 545–554
15. Busch, C.; Aktories, K. Microbial toxins and the glycosylation of Rho family GTPases. Curr. Opin. Struct. Biol. 2000, 10, 528–535
16. Aktories, K.; Schmidt, G.; Just, I. Rho GTPases as targets of bacterial protein toxins. Biol. Chem. 2000, 381, 421–426
17. Hall, A. Rho GTPases and the actin cytoskeleton. Science 1998, 279, 509–514
18. Hall, A. Ras-related GTPases and the cytoskeleton. Mol. Cell Biol.1992, 3, 475–479
19. Coso, O.A.; Chiariello, M.; Yu, J.C.; Teramoto, H.; Crespo, P.; Xu, N.; Miki, T.; Gutkind, J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995, 81, 1137–1146
20. Minden, A.; Lin, A.; Claret, F.X.; Abo, A.; Karin, M. Selective activation of the JNK signaling cascade and c-jun transcriptional activity by the small GTPases Rac and Cdc42hs. Cell 1995, 81, 1147–1157
21. Canman, C.E.; Kastan, M.B. Three paths to stress relief. Nature 1996, 384, 213–214
22. Verheij, M.; Bose, R.; Lin, X.H.; Yao, B.; Jarvis, W.D.; Grant, S.; Birrer, M.J.; Szabo, E.; Zon, L.I.; Kyriakis, J.M.; et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380, 75–79
23. Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R.J.; Greenberg, M.E. Opposing effects of ERK and JNK-p38 map kinases on apoptosis. Science 1995, 270, 1326–1331
24. Hayakawa, J.; Depatie, C.; Ohmichi, M.; Mercola, D. The activation of c-jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J. Biol. Chem. 2003, 278, 20582–20592
25. Perona, R.; Montaner, S.; Saniger, L.; Sanchez-Perez, I.; Bravo, R.; Lacal, J.C. Activation of the nuclear factor-κB by Rho, Cdc42, and Rac-1 proteins. Genes Dev. 1997, 11, 463–475
26. Schmitz, A.A.; Govek, E.E.; Bottner, B.; van Aelst, L. Rho GTPases: Signaling, migration, and invasion. Exp. Cell Res. 2000, 261, 1–12
27. Jaffe, A.B.; Hall, A. Rho GTPases in transformation and metastasis. Adv. Cancer Res.2002, 84, 57–80
28. Ridley, A.J. Rho proteins and cancer. Breast Cancer Res. Treat. 2004, 84, 13–19
29. Braga, V.M.; Machesky, L.M.; Hall, A.; Hotchin, N.A. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J. Cell Biol. 1997, 137, 1421–1431
30. Ridley, A.J.; Hall, A. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70, 389–399
31. Olson, M.F.; Ashworth, A.; Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995, 269, 1270–1272
32. Aznar, S.; Lacal, J.C. Rho signals to cell growth and apoptosis. Cancer Lett.2001, 165, 1–10
33. Knebel, A.; Rahmsdorf, H.J.; Ullrich, A.; Herrlich, P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 1996, 15, 5314–5325
34. Sachsenmaier, C.; Radler-Pohl, A.; Zinck, R.; Nordheim, A.; Herrlich, P.; Rahmsdorf, H.J. Involvement of growth factor receptors in the mammalian uvc response. Cell 1994, 78, 963–972
35. Herrlich, P.; Karin, M.; Weiss, C. Supreme enlightenment: Damage recognition and signaling in the mammalian UV response. Mol. Cell 2008, 29, 279–290
36. Gross, S.; Knebel, A.; Tenev, T.; Neininger, A.; Gaestel, M.; Herrlich, P.; Bohmer, F.D. Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction. J. Biol. Chem. 1999, 274, 26378–26386
37. Ichijo, H. From receptors to stress-activated map kinases. Oncogene 1999, 18, 6087–6093
38. Liu, Z.G.; Baskaran, R.; Lea-Chou, E.T.; Wood, L.D.; Chen, Y.; Karin, M.; Wang, J.Y. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 1996, 384, 273–276
39. Wang, J.Y. Regulation of cell death by the Abl tyrosine kinase. Oncogene 2000, 19, 5643–5650
40. Kharbanda, S.; Ren, R.; Pandey, P.; Shafman, T.D.; Feller, S.M.; Weichselbaum, R.R.; Kufe, D.W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 1995, 376, 785–788
41. Nehme, A.; Baskaran, R.; Aebi, S.; Fink, D.; Nebel, S.; Cenni, B.; Wang, J.Y.; Howell, S.B.; Christen, R.D. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 1997, 57, 3253–3257
42. Shaulian, E.; Karin, M. Ap-1 as a regulator of cell life and death. Nat. Cell Biol.2002, 4, E131–E136
43. Fritz, G.; Kaina, B. Late activation of stress kinases (SAPK/JNK) by genotoxins requires the DNA repair proteins DNA-PKcs and CSB. Mol. Biol. Cell 2006, 17, 851–861
44. Nehme, A.; Baskaran, R.; Nebel, S.; Fink, D.; Howell, S.B.; Wang, J.Y.; Christen, R.D. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br. J. Cancer 1999, 79, 1104–1110
45. Damrot, J.; Helbig, L.; Roos, W.P.; Barrantes, S.Q.; Kaina, B.; Fritz, G. DNA replication arrest in response to genotoxic stress provokes early activation of stress-activated protein kinases (SAPK/JNK). J. Mol. Biol.2009, 385, 1409–1421
46. Harper, J.W.; Elledge, S.J. The DNA damage response: Ten years after. Mol. Cell 2007, 28, 739–745
47. De Feraudy, S.; Revet, I.; Bezrookove, V.; Feeney, L.; Cleaver, J.E. A minority of foci or pan-nuclear apoptotic staining of γH2AX in the s phase after UV damage contain DNA doublestrand breaks. Proc. Natl. Acad. Sci. USA 2010, 107, 6870–6875
48. Lu, C.; Zhu, F.; Cho, Y.Y.; Tang, F.; Zykova, T.; Ma, W.Y.; Bode, A.M.; Dong, Z. Cell apoptosis: Requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol. Cell 2006, 23, 121–132
49. Sluss, H.K.; Davis, R.J. H2AX is a target of the JNK signaling pathway that is required for apoptotic DNA fragmentation. Mol. Cell 2006, 23, 152–153
50. Bonner, W.M.; Redon, C.E.; Dickey, J.S.; Nakamura, A.J.; Sedelnikova, O.A.; Solier, S.; Pommier, Y. γH2AX and cancer. Nat. Rev. Cancer 2008, 8, 957–967
51. Kopper, F.; Bierwirth, C.; Schon, M.; Kunze, M.; Elvers, I.; Kranz, D.; Saini, P.; Menon, M.B.; Walter, D.; Sorensen, C.S., et al. Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. Proc. Natl. Acad. Sci. USA 2013, 110, 16856–16861
52. Reinhardt, H.C.; Hasskamp, P.; Schmedding, I.; Morandell, S.; van Vugt, M.A.; Wang, X.; Linding, R.; Ong, S.E.; Weaver, D.; Carr, S.A., et al. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated rna stabilization. Mol. Cell 2010, 40, 34–49
53. Reinhardt, H.C.; Yaffe, M.B. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 2009, 21, 245–255
54. Reinhardt, H.C.; Aslanian, A.S.; Lees, J.A.; Yaffe, M.B. P53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007, 11, 175–189
55. Gnad, R.; Aktories, K.; Kaina, B.; Fritz, G. Inhibition of protein isoprenylation impairs Rho-regulated early cellular response to genotoxic stress. Mol. Pharmacol.2000, 58, 1389–1397
56. Rashid, M.; Tawara, S.; Fukumoto, Y.; Seto, M.; Yano, K.; Shimokawa, H. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-coA reductase inhibitors. Circ. J. 2009, 73, 361–370
57. Zhou, Q.; Liao, J.K. Pleiotropic effects of statins—Basic research and clinical perspectives. Circ. J. 2010, 74, 818–826
58. Endres, M.; Laufs, U. Effects of statins on endothelium and signaling mechanisms. Stroke 2004, 35, 2708–2711
59. Fritz, G.; Kaina, B. Rho GTPases: Promising cellular targets for novel anticancer drugs. Curr. Cancer Drug Targets 2006, 6, 1–14
60. Fritz, G. Targeting the mevalonate pathway for improved anticancer therapy. Curr. Cancer Drug Targets 2009, 9, 626–638
61. Damrot, J.; Nubel, T.; Epe, B.; Roos, W.P.; Kaina, B.; Fritz, G. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. Br. J. Pharmacol.2006, 149, 988–997
62. Nilsson, S.; Huelsenbeck, J.; Fritz, G. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells. Cancer Lett.2011, 304, 60–69
63. Helbig, L.; Damrot, J.; Hulsenbeck, J.; Koberle, B.; Brozovic, A.; Osmak, M.; Fiket, Z.; Kaina, B.; Fritz, G. Late activation of stress-activated protein kinases/c-jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells. J. Biol. Chem.2011, 286, 12991–13001
64. Devary, Y.; Gottlieb, R.A.; Smeal, T.; Karin, M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992, 71, 1081–1091
65. Onesto, C.; Shutes, A.; Picard, V.; Schweighoffer, F.; Der, C.J. Characterization of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. Methods Enzymol. 2008, 439, 111–129
66. Gao, Y.; Dickerson, J.B.; Guo, F.; Zheng, J.; Zheng, Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 2004, 101, 7618–7623
67. Huelsenbeck, S.C.; Schorr, A.; Roos, W.P.; Huelsenbeck, J.; Henninger, C.; Kaina, B.; Fritz, G. Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons. J. Biol. Chem.2012, 287, 38590–38599
68. Huelsenbeck, J.; Henninger, C.; Schad, A.; Lackner, K.J.; Kaina, B.; Fritz, G. Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity. Cell Death Dis. 2011, doi:10.1038/cddis.2011.65
69. Wartlick, F.; Bopp, A.; Henninger, C.; Fritz, G. DNA damage response (DDR) induced by topoisomerase ii poisons requires nuclear function of the small GTPase Rac. Biochim. Biophys. Acta 2013, 1833, 3093–3103
70. Riad, A.; Bien, S.; Westermann, D.; Becher, P.M.; Loya, K.; Landmesser, U.; Kroemer, H.K.; Schultheiss, H.P.; Tschope, C. Pretreatment with statin attenuates the cardiotoxicity of doxorubicin in mice. Cancer Res. 2009, 69, 695–699
71. Yoshida, M.; Shiojima, I.; Ikeda, H.; Komuro, I. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J. Mol. Cell Cardiol. 2009, 47, 698–705
72. Ma, J.; Wang, Y.; Zheng, D.; Wei, M.; Xu, H.; Peng, T. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways. Cardiovasc. Res.2013, 97, 77–87
73. Henninger, C.; Huelsenbeck, S.; Wenzel, P.; Brand, M.; Huelsenbeck, J.; Schad, A.; Fritz, G. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin. Pharmacol. Res. 2015, 91, 47–56
74. Smith, J.; Tho, L.M.; Xu, N.; Gillespie, D.A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res.2010, 108, 73–112
75. Bopp, A.; Wartlick, F.; Henninger, C.; Kaina, B.; Fritz, G. Rac1 modulates acute and subacute genotoxin-induced hepatic stress responses, fibrosis and liver aging. Cell Death Dis.2013, doi:10.1038/cddis.2013.57
76. Bopp, A.; Wartlick, F.; Henninger, C.; Schwarz, M.; Kaina, B.; Fritz, G. Rac1 promotes diethylnitrosamine (den)-induced formation of liver tumors. Carcinogenesis 2015, 36, 378–389
77. Paajarvi, G.; Roudier, E.; Crisby, M.; Hogberg, J.; Stenius, U. HMG-coA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. FASEB J. 2005, 19, 476–478
78. Mahmoudi, M.; Gorenne, I.; Mercer, J.; Figg, N.; Littlewood, T.; Bennett, M. Statins use a novel nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ. Res. 2008, 103, 717–725
79. Baskaran, R.; Wood, L.D.; Whitaker, L.L.; Canman, C.E.; Morgan, S.E.; Xu, Y.; Barlow, C.; Baltimore, D.; Wynshaw-Boris, A.; Kastan, M.B., et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 1997, 387, 516–519
80. Gong, J.G.; Costanzo, A.; Yang, H.Q.; Melino, G.; Kaelin, W.G., Jr.; Levrero, M.; Wang, J.Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999, 399, 806–809
81. Yuan, Z.M.; Huang, Y.; Ishiko, T.; Kharbanda, S.; Weichselbaum, R.; Kufe, D. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 1997, 94, 1437–1440
82. Yuan, S.S.; Chang, H.L.; Lee, E.Y. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM−/− and c-Abl−/− cells. Mutat. Res. 2003, 525, 85–92
83. Chen, G.; Yuan Shyng Shiou, F.; Liu, W.; Xu, Y.; Trujillo, K.; Song, B.; Cong, F.; Goff Stephen, P.; Wu, Y.; Arlinghaus, R.; et al. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 1999, 274, 12748–12752
84. Kharbanda, S.; Yuan Zhi, M.; Weichselbaum, R.; Kufe, D. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 1998, 17, 3309–3318
85. Wang, X.; Zeng, L.; Wang, J.; Chau, J.F.; Lai, K.P.; Jia, D.; Poonepalli, A.; Hande, M.P.; Liu, H.; He, G.; et al. A positive role for c-Abl in ATM and ATR activation in DNA damage response. Cell Death Differ. 2011, 18, 5–15
86. Yoshida, K.; Yamaguchi, T.; Natsume, T.; Kufe, D.; Miki, Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol.2005, 7, 278–285
87. Zandy, N.L.; Playford, M.; Pendergast, A.M. Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases. Proc. Natl. Acad. Sci. USA 2007, 104, 17686–17691
88. Bassermann, F.; Jahn, T.; Miething, C.; Seipel, P.; Bai, R.Y.; Coutinho, S.; Tybulewicz, V.L.; Peschel, C.; Duyster, J. Association of Bcr-Abl with the proto-oncogene vav is implicated in activation of the Rac-1 pathway. J. Biol. Chem.2002, 277, 12437–12445
89. Sandrock, K.; Bielek, H.; Schradi, K.; Schmidt, G.; Klugbauer, N. The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin α2. Traffic 2010, 11, 198–209
90. Michaelson, D.; Abidi, W.; Guardavaccaro, D.; Zhou, M.; Ahearn, I.; Pagano, M.; Philips, M.R. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J. Cell Biol. 2008, 181, 485–496
91. Yan, Y.; Greer, P.M.; Cao, P.T.; Kolb, R.H.; Cowan, K.H. Rac1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation. Breast Cancer Res. 2012, doi:10.1186/bcr3164
92. Dion, V.; Shimada, K.; Gasser, S.M. Actin-related proteins in the nucleus: Life beyond chromatin remodelers. Curr. Opin. Cell Biol. 2010, 22, 383–391
93. Hinde, E.; Yokomori, K.; Gaus, K.; Hahn, K.M.; Gratton, E. Fluctuation-based imaging of nuclear Rac1 activation by protein oligomerisation. Sci. Rep. 2014, doi:10.1038/srep04219
94. Hajas, G.; Bacsi, A.; Aguilera-Aguirre, L.; Hegde, M.L.; Tapas, K.H.; Sur, S.; Radak, Z.; Ba, X.; Boldogh, I. 8-Oxoguanine DNA glycosylase-1 links DNA repair to cellular signaling via the activation of the small GTPase Rac1. Free Radic. Biol. Med. 2013, 61, 384–394
95. Motwani, M.; Li, D.Q.; Horvath, A.; Kumar, R. Identification of novel gene targets and functions of p21-activated kinase 1 during DNA damage by gene expression profiling. PLoS ONE 2013, doi:10.1371/journal.pone.0066585
96. Yoshii, S.; Tanaka, M.; Otsuki, Y.; Fujiyama, T.; Kataoka, H.; Arai, H.; Hanai, H.; Sugimura, H. Involvement of α-PAK-interacting exchange factor in the PAK1-c-jun NH2-terminal kinase 1 activation and apoptosis induced by benzo[a]pyrene. Mol. Cell Biol 2001, 21, 6796–6807
97. Guerra, L.; Carr, H.S.; Richter-Dahlfors, A.; Masucci, M.G.; Thelestam, M.; Frost, J.A.; Frisan, T. A bacterial cytotoxin identifies the RhoA exchange factor net1 as a key effector in the response to DNA damage. PLoS ONE 2008, doi:10.1371/journal.pone.0002254
98. Guerra, L.; Guidi, R.; Slot, I.; Callegari, S.; Sompallae, R.; Pickett, C.L.; Astrom, S.; Eisele, F.; Wolf, D.; Sjogren, C.; et al. Bacterial genotoxin triggers fen1-dependent RhoA activation, cytoskeleton remodeling and cell survival. J. Cell Sci.2011, 124, 2735–2742
99. Maekawa, M.; Ishizaki, T.; Boku, S.; Watanabe, N.; Fujita, A.; Iwamatsu, A.; Obinata, T.; Ohashi, K.; Mizuno, K.; Narumiya, S. Signaling from Rho to the actin cytoskeleton through protein kinases rock and lim-kinase. Science 1999, 285, 895–898
100. Carr, H.S.; Morris, C.A.; Menon, S.; Song, E.H.; Frost, J.A. Rac1 controls the subcellular localization of the Rho guanine nucleotide exchange factor net1a to regulate focal adhesion formation and cell spreading. Mol. Cell Biol. 2013, 33, 622–634
101. Plessner, M.; Melak, M.; Chinchilla, P.; Baarlink, C.; Grosse, R. Nuclear f-actin formation and reorganization upon cell spreading. J. Biol. Chem. 2015, 290, 11209–11216
102. Navarro-Lerida, I.; Pellinen, T.; Sanchez, S.A.; Guadamillas, M.C.; Wang, Y.; Mirtti, T.; Calvo, E.; del Pozo, M.A. Rac1 nucleocytoplasmic shuttling drives nuclear shape changes and tumor invasion. Dev. Cell 2015, 32, 318–334
103. Meng, X.; Yuan, Y.; Maestas, A.; Shen, Z. Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280. J. Biol. Chem. 2004, 279, 6098–6105
104. Andrin, C.; McDonald, D.; Attwood, K.M.; Rodrigue, A.; Ghosh, S.; Mirzayans, R.; Masson, J.Y.; Dellaire, G.; Hendzel, M.J. A requirement for polymerized actin in DNA double-strand break repair. Nucleus 2012, 3, 384–395
105. Kumar, A.; Mazzanti, M.; Mistrik, M.; Kosar, M.; Beznoussenko, G.V.; Mironov, A.A.; Garre, M.; Parazzoli, D.; Shivashankar, G.V.; Scita, G., et al. ATR mediates a checkpoint at the nuclear envelope in response to mechanical stress. Cell 2014, 158, 633–646
106. Moore, K.A.; Sethi, R.; Doanes, A.M.; Johnson, T.M.; Pracyk, J.B.; Kirby, M.; Irani, K.; Goldschmidt-Clermont, P.J.; Finkel, T. Rac1 is required for cell proliferation and G2/M progression. Biochem. J. 1997, 326, 17–20
107. Zuo, Y.; Oh, W.; Frost, J.A. Controlling the switches: Rho GTPase regulation during animal cell mitosis. Cell Signal 2014, 26, 2998–3006
108. Chircop, M. Rho GTPases as regulators of mitosis and cytokinesis in mammalian cells. Small GTPases 2014, doi:10.4161/sgtp.29770
109. Yoshizaki, H.; Ohba, Y.; Kurokawa, K.; Itoh, R.E.; Nakamura, T.; Mochizuki, N.; Nagashima, K.; Matsuda, M. Activity of Rho-family GTPases during cell division as visualized with fret-based probes. J. Cell Biol. 2003, 162, 223–232
110. Fromigue, O.; Hamidouche, Z.; Marie, P.J. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. J. Pharmacol. Exp. Ther. 2008, 325, 595–600
111. Feleszko, W.; Mlynarczuk, I.; Balkowiec-Iskra, E.Z.; Czajka, A.; Switaj, T.; Stoklosa, T.; Giermasz, A.; Jakobisiak, M. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice. Clin. Cancer Res. 2000, 6, 2044–2052
112. Bourgier, C.; Haydont, V.; Milliat, F.; Francois, A.; Holler, V.; Lasser, P.; Bourhis, J.; Mathe, D.; Vozenin-Brotons, M.C. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 2005, 54, 336–343
113. Haydont, V.; Bourgier, C.; Vozenin-Brotons, M.C. Rho/rock pathway as a molecular target for modulation of intestinal radiation-induced toxicity. Br. J. Radiol.2007, 80, 32–40
114. Iseri, S.; Ercan, F.; Gedik, N.; Yuksel, M.; Alican, I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007, 230, 256–264
115. An, Y.; Xin, H.; Yan, W.; Zhou, X. Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Exp. Toxicol. Pathol. 2011, 63, 215–219
116. Liu, Y.; Tang, W.; Wang, J.; Xie, L.; Li, T.; He, Y.; Deng, Y.; Peng, Q.; Li, S.; Qin, X. Association between statin use and colorectal cancer risk: A meta-analysis of 42 studies. Cancer Causes Control 2014, 25, 237–249
117. Narisawa, T.; Fukaura, Y.; Terada, K.; Umezawa, A.; Tanida, N.; Yazawa, K.; Ishikawa, C. Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-coA reductase inhibitors, pravastatin and simvastatin, in icr mice. Carcinogenesis 1994, 15, 2045–2048
118. Tiede, I.; Fritz, G.; Strand, S.; Poppe, D.; Dvorsky, R.; Strand, D.; Lehr, H.A.; Wirtz, S.; Becker, C.; Atreya, R., et al. Cd28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J. Clin. Invest.2003, 111, 1133–1145
119. Guerra, L.; Cortes-Bratti, X.; Guidi, R.; Frisan, T. The biology of the cytolethal distending toxins. Toxins 2011, 3, 172–190
120. Ohara, M.; Oswald, E.; Sugai, M. Cytolethal distending toxin: A bacterial bullet targeted to nucleus. J. Biochem. 2004, 136, 409–413
121. Bezine, E.; Vignard, J.; Mirey, G. The cytolethal distending toxin effects on mammalian cells: A DNA damage perspective. Cells 2014, 3, 592–615
122. Fahrer, J.; Huelsenbeck, J.; Jaurich, H.; Dorsam, B.; Frisan, T.; Eich, M.; Roos, W.P.; Kaina, B.; Fritz, G. Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts. DNA Repair 2014, 18, 31–43
123. Lara-Tejero, M.; Galan, J.E. Cytolethal distending toxin: Limited damage as a strategy to modulate cellular functions. Trends Microbiol. 2002, 10, 147–152
124. Sugihara, K.; Nakatsuji, N.; Nakamura, K.; Nakao, K.; Hashimoto, R.; Otani, H.; Sakagami, H.; Kondo, H.; Nozawa, S.; Aiba, A., et al. Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 1998, 17, 3427–3433.